U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511361) titled 'Study of Efficacy and Safety of Tonlamarsen in Participants With Acute Severe Hypertension Recently Discharged From the Hospital' on March 28.
Brief Summary: The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently discharged from the hospital, after treatment for acute severe hypertension.
Study Start Date: April 20
Study Type: INTERVENTIONAL
Condition:
Hypertension
Acute Severe Hypertension
Intervention:
DRUG: Tonlamarsen
Tonlamarsen will be administered subcutaneously (under the skin) every 4 weeks during the randomized part of the study
DRUG: Place...